Does GAD have a unique role in triggering IDDM?

Journal of Autoimmunity

Volumn 15, Issue 3, 2000, Pages 279-286

  Baekkeskov, Steinunn ^a   Kanaani, Jamil ^a   Jaume, Juan Carlos ^a   Kash, Shera ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE DECARBOXYLASE;

ANTIGEN EXPRESSION; AUTOIMMUNITY; IMMUNE RESPONSE; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0033694973     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.2000.0443     Document Type: Review

References (78)

1. The pancreatic islets in diabetes
2. The pancreas in recentonset type 1 (insulin dependent) diabetes mellitus: Insulin content of islets, insulinitis and associated changes in the exocrine acinar tissue
3. Insulin-dependent diabetes mellitus
4. The role of CD4 and CD8 T cells in the development of autoimmune diabetes
5. The role of CD4 vs. CD8 T cells in IDDM
6. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice
7. Susceptibility to type 1 diabetes: HLA-DQ and DR revisited
8. The role of MHC class II molecules in susceptibility and resistance to autoimmunity
9. The first external domain of the non-obese diabetic mouse class II I-Aβ chain is unique
10. Autoantibodies in newly diagnosed diabetic children immunoprecipitate specific human pancreatic islet cell proteins
11. Antibodies to a Mr 64,000 human islet cell antigen precede the clinical onset of insulin-dependent diabetes
12. 64,000 M(r) autoantibodies as predictors of insulin dependent diabetes
13. Antibodies to a Mr 64,000 islet cell protein in Swedish children with newly diagnosed type 1 (insulin dependent diabetes)
14. The 64-kDa beta cell membrane autoantigen and other target molecules of humoral autoimmunity in insulin dependent diabetes mellitus
15. Revelation of specificity of 64K autoantibodies in IDDM serums by high resolution 2-D gel electrophoresis
16. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase
17. Distinct antibody specificities to a 64-kD islet cell antigen in type 1 diabetes as revealed by trypsin treatment
18. Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512)
19. The 37/40-kilodalton autoantigen in insulin-dependent diabetes mellitus is the putative tyrosine phosphatase IA-2
20. Islet cell antigen 512 is a diabetes-specific islets autoantigen related to protein tyrosine phosphatases
21. Identification and characterization of Glima 38, a glycosylated islet cell membrane antigen, which together with GAD65 and IA2 marks the early phases of autoimmune response in type 1 diabetes
22. High resolution epitope mapping and structural modeling of human glutamic acid decarboxylase 65
23. Naturally processed T Cell epitopes from glutamic acid decarboxylase identified using mice transgenic For the type 1 diabetes-associated human MHC class II allele, DRB1*0401
24. Identification of immunodominant T cell epitopes of human glutamic acid decarboxylase 65 by using HLA-DR (alpha1*0101,beta1*0401) transgenic mice
25. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients
26. Autoantibodies in IDDM primarily recognize the 65,00-M(r) rather than the 67,000-M(r) isoform of glutamic acid decarboxylase
27. Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in type 1 diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression
28. Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic islets
29. Differential expression of glutamic acid decarboxylase in rat and human islets
30. Increased expression of GAD65 and GABA in pancreatic β-cells impairs first-phase insulin secretion
31. Alternative splicing of GAD 67 results in the synthesis of a third form of glutamic-acid decarboxylase in human islets and other non-neural tissues
32. Identification of the 37-kDa antigen in IDDM as a tyrosine phosphatase-like protein (phogrin) related to IA-2
33. Cross reactivity between IA-2 and phogrin/IA-2beta in binding of autoantibodies in IDDM
34. Combined antibody screening for improved prediction of IDDM-Modern strategies
35. A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus
36. Recognition of common islet antigen by autoantibodies from NOD mice and humans with IDDM
37. Sex-determining region Y-related protein SOX13 is a diabetes autoantigen expressed in pancreatic islets
38. Peptide mapping and characterization of glycosylation patterns of the glima 38 antigen recognized by autoantibodies in Type 1 diabetic patients
39. Multiple sclerosis: A coordinated immunological attack against myelin in the central nervous system
40. Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis
41. Immunoglobin variable gene analysis of human autoantibodies reveals antigen-driven immune response to glutamate decarboxylase in type 1 diabetes mellitus
42. Characterization of self-glutamic acid decarboxylase 65-reactive CD4+ T-cell clones established from Japanese patients with insulin-dependent diabetes mellitus
43. T-cell lines reactive to an immunodominant epitope of the tyrosine phosphate-like autoantigen IA-2 type 1 diabetes
44. Cloned T cells from a recent onset of IDDM potent reactive with insulin B-chain
45. Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes
46. Antibodies to ICA512/IA-2 in rodent models of IDDM
47. Spontaneous loss of T cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes
48. Immune response to glutamic acid decarboxylase correlates with insulitis in nonobese diabetic mice
49. Administering glutamic acid decarboxylase to NOD mice prevents diabetes
50. Induction of GAD65 specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice
51. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent
52. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes
53. Modulating auto-immune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice
54. 67) prevents autoimmune diabetes in NOD mice
55. Determinant spread of T helper cell 2 (Th2) responses to pancreatic islet autoantigens
56. GAD-reactive CD4+ Th1 cells induce diabetes in NOD/SCID mice
57. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice
58. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library
59. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin
60. Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon gamma transcription
61. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)
62. Aerosol insulin reduces regulatory CD8 γδ T cells that prevent murine insulin-dependent diabetes
63. Metabolically inactive insulin analog prevents type 1 diabetes in prediabetic NOD mice
64. Protection from insulin dependent diabetes mellitus afforded by insulin antigens in incomplete Freund's adjuvant depends on route of administration
65. Localization and quantitation of expression of two glutamate decarboxylase genes in pancreatic beta-cells and other peripheral tissues of mouse and rat
66. Epilepsy in mice deficient in the 65 kDa isoform of glutamic acid decarboxylase
67. Increased anxiety and altered responses to anxiolytics in mice deficient in the 65 kDa isoform of glutamic acid decarboxylase
68. Local GABA circuit control of experience-dependent plasticity in developing visual cortex
69. GABA in brain and pancreas: Lessons from knock-out mice
70. Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase
71. Cleft palate in mice with a targeted mutation in the gamma-aminobutyric acid-producing enzyme glutamic acid decarboxylase 67
72. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in β cells
73. Control of autoimmune diabetes
74. Control of autoimune diabetes
75. Control of autoimmune diabetes
76. Islet-specific T-cell clones from the NOD mouse respond to beta-granule antigen
77. Immunostimulatory DNS sequences necessary for effective intradermal gene immunization
78. DNA vaccines: A novel approach to immunization